Press-release for stocks for finch therapeutics group inc

Prices are updated after-hours

Finch Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
Published: 2021-08-10 (Crawled : 18:00) - biospace.com/
FNCH | $2.305 -17.35% -20.99% 120K

| -83.32% | O: 8.77% H: 0.0% C: -6.67%
financial results results

Finch Therapeutics Announces Takeda to Accelerate Leadership Role in FIN-524 Ulcerative Colitis Development Program
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
FNCH | $2.305 -17.35% -20.99% 120K

| -83.32% | O: 8.77% H: 0.0% C: -6.67%
TAK | News | $13.23 -1.12% 0.0% 920K

| -19.43% | O: -0.85% H: 0.98% C: 0.43%
ulcerative colitis

62%

38%

CSSE 4 | $0.4323 183.85% 64.77% 220M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.